HOME >> MEDICINE >> NEWS
The CARDIA Study: Statement from Dr. Claude Lenfant, director, National Heart, Lung, and Blood Institute

Note to reporters/editors:

The October 27, 1999, issue of the Journal of the American Medical Association (JAMA) spotlights the health risks of obesity, a major risk factor for heart disease. About 97 million American adults --55 percent of the population-- are now overweight or obese.

The JAMA issue includes three articles on research supported by the National Heart, Lung, and Blood Institute (NHLBI):

"Dietary Fiber, Weight Gain, and Cardiovascular Disease Risk Factors in Young Adults." This report examines the association of fiber consumption to insulin levels and the risk of cardiovascular disease (CVD). The researchers reviewed data from the multicenter NHLBI Coronary Artery Risk Development in Young Adults (CARDIA) Study. The attached statement describes the study of nearly 3,000 black and white young adults in more detail. The authors conclude that high-fiber diets may protect against obesity and CVD by lowering insulin levels. Catherine Loria, Ph.D., Epidemiologist, NHLBI, is available for comment on this study.

"Effects of Intermittent Exercise and Use of Home Exercise Equipment on Adherence, Weight Loss, and Fitness in Overweight Women." The researchers from Brown University and the University of Pittsburgh conducted an 18-month trial with overweight women. They found that, contrary to expectation, advice to exercise in short bouts rather than long bouts did not increase sustained adherence or long-term weight loss. However, the provision of home exercise equipment improved weight loss for those advised to exercise in short bouts compared with those advised to exercise in short bouts but were not provided equipment. Eva Obarzanek, Ph.D., Research Nutritionist, NHLBI, is available for comment on this study.

"Reducing Children's Television Viewing to Prevent Obesity." Dr. Thomas N. Robinson of Stanford University gives results of a trial that involved about 190 elementary school children. Chi
'"/>

Contact: NHLBI Communications Office
301-496-4236
NIH/National Heart, Lung, and Blood Institute
25-Oct-1999


Page: 1 2 3

Related medicine news :

1. Study: Two brain systems regulate how we call for help
2. Study: Eye contact triggers threat signals in autistic childrens brains
3. Study: Young adults can be motivated to eat fruits, veggies
4. Study: Physical activity in middle age cuts risk of early death
5. Study: Brain battles itself over short-term rewards, long-term goals
6. Study: Dementia often undiagnosed in clinical settings
7. Study: Too few doctors ask teens about smoking
8. Study: Low-carb diet more effective than low-fat diet
9. Study: Many men take dietary supplements to prevent prostate cancer
10. Study: Height loss screen ultimately could reduce hip fractures
11. Study: New neurons can get out of spinal cord

Post Your Comments:
(Date:5/29/2015)... May 29, 2015 Johnson & ... a confidential Risperdal lawsuit ( http://www.risperdallawsuit2014.com/ ) settlement ... due to his use of the antipsychotic medication. ... selected for the third bellwether trial to involve ... litigation underway in Pennsylvania’s Philadelphia Court of Common ...
(Date:5/29/2015)... California (PRWEB) May 29, 2015 A group ... and have joined the national effort to teach this “new ... in the U.S. have been “sickened” by the recent implementation ... love it or hate it, Common Core is now a ... of Columbia. Parents are now seeking ways to improve ...
(Date:5/29/2015)... May 29, 2015 Intermountain ... partnered with Stratus Video Interpreting ... facilitate better communication and timely care for ... hearing loss. Stratus’ video remote interpreting (VRI) ... enabling staff to quickly access qualified medical ...
(Date:5/29/2015)... 29, 2015 The print component of ... circulation of approximately 250,000 and an estimated readership of ... vast social media strategy, and across a network of ... digital version of the campaign, click here. ... publication. Inside, the actress, model and producer details her ...
(Date:5/29/2015)... (PRWEB) May 29, 2015 Mediaplanet has ... “beauty of protection”. Skin Health is a cross-platform ... within the markets of New York, Los Angeles, and ... 750,000 readers. Its digital counterpart will reach a national ... To read more the Skin Health campaign and Colorescience, ...
Breaking Medicine News(10 mins):Health News:Risperdal Lawsuit Selected as Pennsylvania’s Third Bellwether Gynecomastia Case Settles Hours Before Trial 2Health News:Risperdal Lawsuit Selected as Pennsylvania’s Third Bellwether Gynecomastia Case Settles Hours Before Trial 3Health News:Doctors Discover a Cure for the Common Core 2Health News:Stratus Video Interpreting Partners With Intermountain Healthcare to Provide On-Demand Interpretation Services for Patients With Limited English Proficiency (LEP) 2Health News:Stratus Video Interpreting Partners With Intermountain Healthcare to Provide On-Demand Interpretation Services for Patients With Limited English Proficiency (LEP) 3Health News:Stratus Video Interpreting Partners With Intermountain Healthcare to Provide On-Demand Interpretation Services for Patients With Limited English Proficiency (LEP) 4Health News:Mediaplanet Launches “Skin Health” Campaign Featuring Colorescience 2
(Date:5/29/2015)... MISSISSAUGA, ON , May 29, 2015 /CNW/ ... COV), an advanced medical technologies company, is delighted ... quarter ended March 31, 2015, which includes revenue ... for the quarter of $264,340. Revenue from advanced wound ... ended March 31, 2015 increased 24% to $1,742,672 ...
(Date:5/29/2015)... British Columbia and MENLO ... -- DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) ... on developing and commercializing proven cancer therapies in ... at the American Association of Cancer Research ... on the potential for its lead product candidate ...
(Date:5/29/2015)... 2015  Eli Lilly and Company (NYSE: LLY ... that they have entered into a clinical trial collaboration ... investigational anti-PD-L1 immune checkpoint inhibitor, MEDI4736, in combination with ... cancer medicine. The planned study will assess the combination ... The Phase I study is expected to ...
Breaking Medicine Technology:Covalon Announces Strong Second Quarter Results 2Covalon Announces Strong Second Quarter Results 3DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 2DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 3DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 4DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 5Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 2Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 3Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 4Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 5Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 6Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 7Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 8Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 9Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 10Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 11Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 12Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 13Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 14
Cached News: